Upload
others
View
20
Download
0
Embed Size (px)
Citation preview
viii
Index
Acknowledgement ..................................................................................................................... i
Summary ................................................................................................................................... ii
Zussamenfassung ..................................................................................................................... v
Index ...................................................................................................................................... viii
1 Introduction ...................................................................................................................... 1
1.1 Proteomics: an overview ........................................................................................... 1
1.1.1 Proteome .................................................................................................................. 1
1.1.2 Significance of post-translational modification (PTM) ........................................... 3
Sulfenation as PTM......................................................................................................... 4
1.2 Ionization techniques in mass spectrometry for proteomics ................................. 6
1.2.1 ESI (Electrospray Ionization) .................................................................................. 6
1.2.2 NSI (Nanospray Ionization) ..................................................................................... 7
1.2.3 MALDI (Matrix Assisted Laser Desorption Ionization) ......................................... 8
1.2.4 ICP (Inductively Coupled Plasma) .......................................................................... 8
1.3 Fragmentation of peptides and proteins using mass spectrometry .................... 10
1.3.1 CID (Collision-induced dissociation) .................................................................... 11
1.3.2 IRMPD (Infrared multiphoton dissociation) ......................................................... 11
1.3.3 HCD (Higher energy collisional dissociation) ...................................................... 12
1.4 Quantification of peptides and proteins using mass spectrometry ..................... 12
1.4.1 Label-free quantitative proteomics ........................................................................ 15
1.4.2 Quantitative proteomics using stable isotope labeling .......................................... 15
Metabolic labeling ........................................................................................................ 15
Enzymatic labeling........................................................................................................ 17
Chemical labeling ......................................................................................................... 17
1.4.3 Quantitative proteomics using bi-functional chelating agents as chemical labels
and lanthanides as mass markers ...................................................................................... 23
ECAT (Element Coded affinity Tag) ............................................................................ 24
MECT (Metal Element Chelate Tag) ............................................................................ 25
1.5 Quantitative proteomics via natural element tags and chemical labels using
inductively coupled plasma mass spectrometry (ICP-MS) ............................................ 25
1.5.1 Via naturally occurring heteroatom tags ............................................................... 26
Sulfur............................................................................................................................. 26
Phosphorus .................................................................................................................... 27
Selenium ....................................................................................................................... 27
1.5.2 Via “artificial” elemental labeling ......................................................................... 28
Iodine ............................................................................................................................ 28
Iron ................................................................................................................................ 28
Mercury ......................................................................................................................... 29
ix
MeCAT (Metal Coded Affinity Tag) using lanthanides ............................................... 29
1.6 Multi-elemental labeling of peptides and proteins ............................................... 31
Polymer-Based Elemental Tags .................................................................................... 31
Nanoparticles ................................................................................................................ 32
2 Aim and Scope of Work ................................................................................................. 34
3 Results and Discussion ................................................................................................... 35
3.1 Dual labeling of peptides using MeCAT and DOTA derivatives ........................ 35
Advantages of cysteinyl-peptide enrichment on Thiopropyl Sepharose 6B resin ........ 38
Optimization of capture/wash/release of cysteinyl-peptide from Thiopropyl Sepharose
6B resin ......................................................................................................................... 39
Optimization of on-resin amino labeling ...................................................................... 40
Evaluation of on-resin amino labeling .......................................................................... 42
Peptide elution from the resin ....................................................................................... 46
Effect of excess TCEP on MeCAT-IA labeling ........................................................... 47
Removal of excess TCEP.............................................................................................. 48
Estimation of losses ...................................................................................................... 49
Thiol labeling and demonstration of dual labeling ....................................................... 50
Methodological scope for quantitative applications using standard addition technique
....................................................................................................................................... 57
Conclusion and Outlook ............................................................................................... 58
3.2 Labeling of proteins and peptides using gold ....................................................... 60
Monomaleimido-Undecagold ....................................................................................... 60
Labeling of protein with Monomaleimido-Undecagold ............................................... 61
C3 LC-ESI-FTICR-MS and LC-ICP-MS analysis of proteins labeled with
Monomaleimido-Undecagold ....................................................................................... 62
SDS-PAGE separation of proteins labeled with Monomaleimido-Undecagold ........... 62
OFFGEL electrophoresis of proteins labeled with Monomaleimido-Undecagold ....... 63
Labeling of peptides with Monomaleimido-Undecagold ............................................. 65
Conclusion and Outlook ............................................................................................... 67
3.3 Quantification of sulfenic acid modifications in peptides and proteins using
molecular and elemental mass spectrometry ................................................................... 68
Synthesis of Ln-DOTA-Dimedone ............................................................................... 71
Purification of Ln-DOTA-Dimedone ........................................................................... 73
In vitro oxidation of cysteine residues and reactivity with dimedone .......................... 76
In vitro oxidation of peptides and labeling with Ln-DOTA-Dimedone ....................... 78
Parallel labeling of peptides with Ln-DOTA-Dimedone and Ln-MeCAT-IA ............. 82
Consecutive labeling of peptides with Ln-DOTA-Dimedone and Ln-MeCAT-IA ...... 83
Optimization of in vitro oxidation of proteins and labeling with Ln-DOTA-Dimedone
....................................................................................................................................... 84
Parallel labeling of proteins with Ln-DOTA-Dimedone and Ln-MeCAT-IA .............. 85
Consecutive labeling of proteins with Ln-DOTA-Dimedone and Ln-MeCAT-IA ...... 86
ESI-MS/MS based relative quantification of sulfenic acid modifications.................... 87
x
Conclusion and Outlook ............................................................................................... 90
4 Materials and Methods .................................................................................................. 92
4.1 Dual labeling of peptides using MeCAT and DOTA derivatives ........................ 92
Chemicals and materials ............................................................................................... 92
Synthesis of Ln-MeCAT-IA ......................................................................................... 92
Proteins and peptides .................................................................................................... 93
Selection of peptides ..................................................................................................... 93
Protein digestion ........................................................................................................... 94
Cysteinyl-peptide enrichment on the Thiopropyl Sepharose 6B resin ......................... 94
On-resin amino labeling ................................................................................................ 94
Peptide elution from the resin and removal of excess TCEP........................................ 95
Cysteine labeling with Ln-MeCAT-IA ......................................................................... 95
C18 nanoLC-ESI-FTICR-MS analysis of labeled peptides ........................................... 95
C18 LC-ESI-FTICR-MS and LC-ICP-MS of labeled peptides ..................................... 96
4.2 Labeling of proteins and peptides using gold ....................................................... 97
Chemicals and materials ............................................................................................... 97
Proteins and peptides .................................................................................................... 97
Labeling of protein with Monomaleimido-Undecagold ............................................... 97
C3 LC-ESI-FTICR-MS and LC-ICP-MS analysis of proteins labeled with
Monomaleimido-Undecagold ....................................................................................... 97
SDS-PAGE separation of proteins labeled with Monomaleimido-Undecagold ........... 98
OFFGEL electrophoresis of proteins labeled with Monomaleimido-Undecagold ....... 98
ICP-MS analysis of OFFGEL fractions ........................................................................ 99
Labeling of peptides with Monomaleimido-Undecagold ............................................. 99
C18 LC-ESI-FTICR-MS and LC-ICP-MS analysis of peptides labeled with
Monomaleimido-Undecagold ....................................................................................... 99
4.3 Quantification of sulfenic acid modifications in peptides and proteins using
molecular and elemental mass spectrometry ................................................................. 100
Chemicals and materials ............................................................................................. 100
Synthesis of Ln-DOTA-Dimedone ............................................................................. 100
LC-UV-MS analysis of the synthesized Ln-DOTA-Dimedone.................................. 101
Purification of the synthesized Ln-DOTA-Dimedone ................................................ 101
Proteins and peptides .................................................................................................. 101
In vitro oxidation of peptides and labeling with dimedone ........................................ 101
In vitro oxidation of peptides and labeling with Ln-DOTA-Dimedone ..................... 101
Labeling of peptides with Ln-MeCAT-IA .................................................................. 102
C18 nanoLC-ESI-FTICR-MS analysis of peptides labeled with dimedone, Ln-DOTA-
Dimedone or Ln-MeCAT-IA ...................................................................................... 102
SCX LC-ICP-MS analysis of p1 labeled with Tb-DOTA-Dimedone or Ho-MeCAT-IA
..................................................................................................................................... 102
Oxidation of proteins and labeling with Ln-DOTA-Dimedone .................................. 103
Labeling of proteins with Ln-MeCAT-IA .................................................................. 103
SDS-PAGE separation of proteins .............................................................................. 103
xi
ICP-MS analysis of protein bands in SDS-PAGE ...................................................... 103
Parallel labeling of peptides and proteins ................................................................... 104
Consecutive labeling of peptides and proteins............................................................ 104
Instrumental parameters for IRMPD and HCD fragmentation ................................... 104
5 References ...................................................................................................................... 106
6 Abbreviations ................................................................................................................ 118
Lebenslauf ............................................................................................................................. 120
Publikationsliste ................................................................................................................... 122